MGTX

MeiraGTx Holdings plc

5.30 USD
+0.01 (+0.28%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

MeiraGTx Holdings plc stock is up 7.94% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 5 May’s closed higher than April.

About MeiraGTx Holdings plc

MeiraGTx Holdings plc focuses on developing treatments for patients with serious diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop a gene therapy treatment using the company's proprietary riboswitch technology.